| Primary |
| Ovulation Induction |
35.0% |
| Product Used For Unknown Indication |
22.3% |
| Infertility |
13.2% |
| Drug Use For Unknown Indication |
5.6% |
| In Vitro Fertilisation |
3.6% |
| Infertility Female |
3.6% |
| Assisted Fertilisation |
2.5% |
| Hypogonadism Male |
2.0% |
| Infertility Male |
1.5% |
| Polycystic Ovaries |
1.5% |
| Uterine Contractions Abnormal |
1.5% |
| Anxiety |
1.0% |
| Azoospermia |
1.0% |
| Cervix Disorder |
1.0% |
| Hypertension |
1.0% |
| Ovarian Disorder |
1.0% |
| Teratospermia |
1.0% |
| Andropause |
0.5% |
| Asthenospermia |
0.5% |
| Blood Testosterone Decreased |
0.5% |
|
| Ectopic Pregnancy |
12.5% |
| Twin Pregnancy |
11.1% |
| Premature Baby |
6.9% |
| Vision Blurred |
6.9% |
| Blood Testosterone Increased |
5.6% |
| Heterotopic Pregnancy |
5.6% |
| Low Birth Weight Baby |
5.6% |
| Maternal Exposure During Pregnancy |
4.2% |
| Ovarian Hyperstimulation Syndrome |
4.2% |
| Polycythaemia Vera |
4.2% |
| Pregnancy |
4.2% |
| Retinopathy Of Prematurity |
4.2% |
| Ruptured Ectopic Pregnancy |
4.2% |
| Vomiting |
4.2% |
| Abortion Spontaneous |
2.8% |
| Dizziness |
2.8% |
| Drug Exposure During Pregnancy |
2.8% |
| Haematocrit Increased |
2.8% |
| Hypertriglyceridaemia |
2.8% |
| Maternal Drugs Affecting Foetus |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
27.1% |
| Polycystic Ovaries |
22.1% |
| Ovulation Induction |
18.4% |
| Product Used For Unknown Indication |
6.4% |
| Assisted Fertilisation |
4.3% |
| Infertility Female |
4.0% |
| Ovarian Disorder |
3.3% |
| Infertility |
2.7% |
| In Vitro Fertilisation |
2.3% |
| Infertile Partner |
2.0% |
| Azoospermia |
1.0% |
| Drug Exposure During Pregnancy |
1.0% |
| Teratospermia |
1.0% |
| Uterine Contractions Abnormal |
1.0% |
| Asthenospermia |
0.7% |
| Cervix Disorder |
0.7% |
| Hypercoagulation |
0.7% |
| Ovulation Disorder |
0.7% |
| Anaesthesia |
0.3% |
| Anovulatory Cycle |
0.3% |
|
| Pregnancy |
30.8% |
| Drug Toxicity |
7.7% |
| Weight Increased |
7.7% |
| Drug Exposure During Pregnancy |
6.4% |
| Respiratory Arrest |
5.1% |
| Pleural Effusion |
3.8% |
| Ruptured Ectopic Pregnancy |
3.8% |
| Twin Pregnancy |
3.8% |
| Drug Ineffective For Unapproved Indication |
2.6% |
| Immotile Cilia Syndrome |
2.6% |
| Maternal Exposure During Pregnancy |
2.6% |
| Multiple Pregnancy |
2.6% |
| Off Label Use |
2.6% |
| Ovarian Hyperstimulation Syndrome |
2.6% |
| Pancreatitis Acute |
2.6% |
| Pericardial Effusion |
2.6% |
| Polycythaemia Vera |
2.6% |
| Premature Labour |
2.6% |
| Vision Blurred |
2.6% |
| Wrong Drug Administered |
2.6% |
|
| Concomitant |
| Ovulation Induction |
12.3% |
| Contraception |
8.2% |
| Polycystic Ovaries |
7.4% |
| Acne |
6.6% |
| Asthma |
6.6% |
| Infertility |
6.6% |
| Drug Use For Unknown Indication |
5.7% |
| Hypertension |
5.7% |
| Migraine |
5.7% |
| Product Used For Unknown Indication |
5.7% |
| Oral Contraception |
4.9% |
| Schizophrenia |
4.9% |
| Ill-defined Disorder |
3.3% |
| In Vitro Fertilisation |
3.3% |
| Nausea |
3.3% |
| Headache |
2.5% |
| Peripartum Cardiomyopathy |
2.5% |
| Bipolar Disorder |
1.6% |
| Blood Testosterone Decreased |
1.6% |
| Epilepsy |
1.6% |
|
| Drug Exposure During Pregnancy |
6.9% |
| Eosinophilic Pneumonia Acute |
6.9% |
| Hypokinesia |
6.9% |
| Injection Site Reaction |
6.9% |
| Nausea |
6.9% |
| Transient Ischaemic Attack |
6.9% |
| Vomiting |
6.9% |
| Weight Increased |
6.9% |
| Wound Infection |
6.9% |
| Abdominal Pain Upper |
3.4% |
| Bile Duct Stone |
3.4% |
| Blood Triglycerides Increased |
3.4% |
| Caesarean Section |
3.4% |
| Chest Pain |
3.4% |
| Cholecystitis Acute |
3.4% |
| Cholecystitis Chronic |
3.4% |
| Cholelithiasis |
3.4% |
| Congenital Cystic Lung |
3.4% |
| Contusion |
3.4% |
| Dyslipidaemia |
3.4% |
|
